| Product Code: ETC7540239 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of cold and flu supplements to India in 2024 saw a notable growth rate of 19.69% compared to the previous year. The top exporting countries to India were the Netherlands, USA, China, Spain, and the UK, indicating a diverse range of sources. Despite this, the market remained moderately concentrated with a stable Herfindahl-Hirschman Index (HHI) in 2024. The compound annual growth rate (CAGR) from 2020 to 2024 stood at 3.5%, reflecting a steady increase in demand for these products in the Indian market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Cold And Flu Supplements Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Cold And Flu Supplements Market Revenues & Volume, 2021 & 2031F |
3.3 India Cold And Flu Supplements Market - Industry Life Cycle |
3.4 India Cold And Flu Supplements Market - Porter's Five Forces |
3.5 India Cold And Flu Supplements Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 India Cold And Flu Supplements Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Cold And Flu Supplements Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about preventive healthcare measures |
4.2.2 Growing demand for natural and herbal supplements |
4.2.3 Rising incidences of cold and flu cases in India |
4.3 Market Restraints |
4.3.1 Lack of stringent regulations and quality control in the supplements industry |
4.3.2 Limited access to healthcare facilities in rural areas |
4.3.3 Competition from traditional remedies and pharmaceutical drugs |
5 India Cold And Flu Supplements Market Trends |
6 India Cold And Flu Supplements Market, By Types |
6.1 India Cold And Flu Supplements Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 India Cold And Flu Supplements Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 India Cold And Flu Supplements Market Revenues & Volume, By Vitamins & Minerals, 2021- 2031F |
6.1.4 India Cold And Flu Supplements Market Revenues & Volume, By Herbal Extracts, 2021- 2031F |
6.1.5 India Cold And Flu Supplements Market Revenues & Volume, By Natural Molecules, 2021- 2031F |
6.2 India Cold And Flu Supplements Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 India Cold And Flu Supplements Market Revenues & Volume, By Pharmacies & Drug Stores, 2021- 2031F |
6.2.3 India Cold And Flu Supplements Market Revenues & Volume, By Hypermarkets & Supermarkets, 2021- 2031F |
6.2.4 India Cold And Flu Supplements Market Revenues & Volume, By Online, 2021- 2031F |
6.2.5 India Cold And Flu Supplements Market Revenues & Volume, By Others, 2021- 2031F |
7 India Cold And Flu Supplements Market Import-Export Trade Statistics |
7.1 India Cold And Flu Supplements Market Export to Major Countries |
7.2 India Cold And Flu Supplements Market Imports from Major Countries |
8 India Cold And Flu Supplements Market Key Performance Indicators |
8.1 Percentage of the population using cold and flu supplements |
8.2 Number of new product launches in the cold and flu supplements market |
8.3 Consumer satisfaction and repeat purchase rate for cold and flu supplements |
9 India Cold And Flu Supplements Market - Opportunity Assessment |
9.1 India Cold And Flu Supplements Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 India Cold And Flu Supplements Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Cold And Flu Supplements Market - Competitive Landscape |
10.1 India Cold And Flu Supplements Market Revenue Share, By Companies, 2024 |
10.2 India Cold And Flu Supplements Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |